UPC logo

Universe Pharmaceuticals (UPC) Company Overview

Profile

Full Name:

Universe Pharmaceuticals INC

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Country:

China

IPO:

March 23, 2021

Indexes:

Not included

Website:

http://www.universe-pharmacy.com

Description:

Universe Pharmaceuticals (UPC) is a company focused on developing and manufacturing high-quality pharmaceutical products. They aim to improve healthcare by providing innovative solutions and affordable medicines. UPC emphasizes research, quality control, and customer satisfaction in its operations to meet the needs of patients and healthcare providers.

Key Details

Price

$0.17

Market Cap

$268.15 K(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$32.31 M(-19.52% YoY)

Annual EPS

-$25.50(+29.46% YoY)

PE Ratio

-

Annual ROE

-14.34%

Annual Debt To Equity

0.14

Beta

0.42

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Feb 6, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 18, 2024

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with UPC included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
Chinese stocks
Stocks below SMA 200
Healthcare sector
All stocks
Earnings this week
Biggest stock gainers today
Stocks with low RSI
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.17
UPC price is $0.17

Price All-time High

$508.50
UPC price is currently -99.97% below its historical high of $508.50

Price Analysts Target

-
UPC price consensus analysts' forecast is unknown

Price Today Change

+5.72%
UPC price is up +5.72% today

Price YTD Change

-71.8%
UPC price is down -71.8% since January 1st

Price 3-Year Change

-99.87%
UPC price is down -99.87% over the past 3 years

Market cap

Market Cap

$268.15 K
UPC market capitalization is $268.15 thousand

Market Cap 3-Year Change

-99.17%
UPC market capitalization is down -99.17% over the past 3 years

Market Cap All-time High

$122.90 M
UPC market capitalization is currently -99.78% below its historical high of $122.90 million

Market Cap Sector Rank

2.27%
UPC market capitalization is higher than 2.27% of companies in Healthcare sector

Technical

Beta

0.42
UPC beta is 0.42

200-day SMA

$23.06
UPC price is currently -99.26% below its 200-day simple moving average

14-day RSI

26.48
UPC 14-day relative strength index is 26.48

30-day Relative Volume

20.24
UPC 30-day relative volume is 20.24

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$32.31 M
UPC annual revenue is $32.31 million

Annual Revenue Analysts Estimate

-
UPC annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-19.52%
UPC annual revenue is down -19.52% year-on-year

Annual Revenue Sector Rank

42.44%
UPC annual revenue is higher than 42.44% of companies in Healthcare sector

Profit

Annual Gross Profit

$10.32 M
UPC annual gross profit is $10.32 million

Annual Gross Margin

31.93%
UPC annual gross profit margin is 31.93%

Annual Operating Profit

-$3.97 M
UPC annual operating income is -$3.97 million

Annual Operating Margin

-12.28%
UPC annual operating profit margin is -12.28%

Annual Net Income

-$6.16 M
UPC annual net profit is -$6.16 million

Annual Net Margin

-19.08%
UPC annual net profit margin is -19.08%

EPS

Annual EPS

-$25.50
UPC annual earnings per share is -$25.50

Annual EPS Analysts Estimate

-
UPC annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+29.46%
UPC annual earnings per share is up +29.46% year-on-year

Annual EPS Sector Rank

8.55%
UPC annual earnings per share is higher than 8.55% of companies in Healthcare sector

ROA & ROE

Annual ROA

-10.92%
UPC annual return on assets is -10.92%

Annual ROE

-14.34%
UPC annual return on equity is -14.34%

EBIT & EBITDA

Annual EBIT

-$3.69 M
UPC annual earnings before interest & taxes is -$3.69 million

Annual EBITDA

-$3.18 M
UPC annual EBITDA is -$3.18 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
UPC price to earnings ratio value is unknown

PE Ratio Sector Rank

-
UPC price to earnings ratio is unknown

PB Ratio

PB Ratio

0.01
UPC price to book ratio is 0.01

PB Ratio Sector Rank

16.91%
UPC price to book ratio is higher than 16.91% of companies in Healthcare sector

PS Ratio

PS Ratio

-
UPC price to sales ratio value is unknown

PS Ratio Sector Rank

-
UPC price to sales ratio is unknown

Enterprise value

Enterprise Value

-$2.08 M
UPC enterprise value is -$2.08 million

Enterprise Value Sector Rank

7.82%
UPC enterprise value is higher than 7.82% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
UPC EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
UPC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.68
UPC annual current ratio is 2.68

Annual Quick Ratio

2.43
UPC annual quick ratio is 2.43

Leverage

Annual Debt To Equity

0.14
UPC annual debt to equity ratio is 0.14

Annual Interest Coverage Ratio

-23.55
UPC annual interest coverage ratio is -23.55

Risk & Stability

Piotroski F-Score

-
UPC piotroski f-score value is unknown

Altman Z-Score

1.18
UPC altman z-score is 1.18

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$53.29 M
UPC annual total assets is $53.29 million

Annual Non Current Assets

$16.48 M
UPC annual long term assets is $16.48 million

Annual Current Assets

$36.81 M
UPC annual total current assets is $36.81 million

Annual Cash & Cash Equivalents

$5.29 M
UPC annual cash & cash equivalents is $5.29 million

Equity

Annual Book Value

$39.53 M
UPC annual book value is $39.53 million

Annual Working Capital

$23.06 M
UPC annual working capital is $23.06 million

Liabilities

Annual Total Liabilities

$13.75 M
UPC annual total liabilities is $13.75 million

Annual Total Long Term Liabilities

$0.00
UPC annual total long term liabilities is $0.00

Annual Current Liabilities

$13.75 M
UPC annual total current liabilities is $13.75 million

Annual Accounts Payable

$4.59 M
UPC annual accounts payable is $4.59 million

Debt

Annual Total Debt

$5.48 M
UPC annual total debt is $5.48 million

Annual Total Debt 1-Year Change

+39.28%
UPC annual total debt is up +39.28% year-on-year

Annual Long Term Debt

-
UPC annual long term debt value is unknown

Annual Short Term Debt

$5.48 M
UPC annual short term debt is $5.48 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$36.27 M
UPC annual total expenses is $36.27 million

Annual Operating Expenses

$14.28 M
UPC annual total operating expenses is $14.28 million

Annual Cost Of Goods Sold

$21.99 M
UPC annual cost of goods sold is $21.99 million

Annual SGA

$9.00 M
UPC annual SGA is $9.00 million

Annual D&A

$508.80 K
UPC annual depreciation & amortization is $508.80 thousand

Annual Interest Expense

$156.80 K
UPC annual interest expense is $156.80 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$1.12 M
UPC annual cash flow from operations is $1.12 million

Annual CFO 1-Year Change

+185.35%
UPC annual cash flow from operations is up +185.35% year-on-year

Annual CFI

-$44.20 K
UPC annual cash flow from investing activities is -$44.20 thousand

Annual CFI 1-Year Change

+98.87%
UPC annual cash flow from investing activities is up +98.87% year-on-year

Annual CFF

-$1.39 M
UPC annual cash flow from financing activities is -$1.39 million

Annual CFF 1-Year Change

-141.91%
UPC annual cash flow from financing activities is down -141.91% year-on-year

Free CashFlow

Annual FCF

$1.08 M
UPC annual free cash flow is $1.08 million

Annual FCF 1-Year Change

+176.52%
UPC annual free cash flow is up +176.52% year-on-year

CAPEX

Annual CAPEX

$44.20 K
UPC annual capital expenditures is $44.20 thousand

Annual CAPEX 1-Year Change

-52.83%
UPC annual capital expenditures is down -52.83% year-on-year

Institutional Ownership

Similar stocks

SRNE logo
Sorrento Therapeutics (SRNE)
TFFP logo
TFF Pharmaceuticals (TFFP)
Fresh2 Group Limited (FRES)
PXMD logo
PaxMedica (PXMD)
NEXI logo
NexImmune (NEXI)
HSTO logo
Histogen (HSTO)
TCON logo
TRACON Pharmaceuticals (TCON)
CYTO logo
Altamira Therapeutics (CYTO)
Holdco Nuvo Group DG (NUVO)
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
UPC
globenewswire.comDecember 10, 2024

New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) of its client Universe Pharmaceuticals INC (NASDAQ: UPC) (the “Company”), a pharmaceutical producer and distributor in China.

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
UPC
globenewswire.comSeptember 20, 2024

JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024.

Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?
Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?
Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?
UPC
InvestorPlaceFebruary 20, 2024

Universe Pharmaceuticals (NASDAQ: UPC ) stock is falling on Tuesday after the company's shares experienced a rally during the prior day of trading. Shares of UPC closed out Friday up 43.9% without any clear news from the traditional Chinese medicine company.

FAQ

  • What is the ticker symbol for Universe Pharmaceuticals?
  • Does Universe Pharmaceuticals pay dividends?
  • What sector is Universe Pharmaceuticals in?
  • What industry is Universe Pharmaceuticals in?
  • What country is Universe Pharmaceuticals based in?
  • When did Universe Pharmaceuticals go public?
  • Is Universe Pharmaceuticals in the S&P 500?
  • Is Universe Pharmaceuticals in the NASDAQ 100?
  • Is Universe Pharmaceuticals in the Dow Jones?
  • When was Universe Pharmaceuticals's last earnings report?
  • When does Universe Pharmaceuticals report earnings?

What is the ticker symbol for Universe Pharmaceuticals?

The ticker symbol for Universe Pharmaceuticals is NASDAQ:UPC

Does Universe Pharmaceuticals pay dividends?

No, Universe Pharmaceuticals does not pay dividends

What sector is Universe Pharmaceuticals in?

Universe Pharmaceuticals is in the Healthcare sector

What industry is Universe Pharmaceuticals in?

Universe Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Universe Pharmaceuticals based in?

Universe Pharmaceuticals is headquartered in China

When did Universe Pharmaceuticals go public?

Universe Pharmaceuticals's initial public offering (IPO) was on March 23, 2021

Is Universe Pharmaceuticals in the S&P 500?

No, Universe Pharmaceuticals is not included in the S&P 500 index

Is Universe Pharmaceuticals in the NASDAQ 100?

No, Universe Pharmaceuticals is not included in the NASDAQ 100 index

Is Universe Pharmaceuticals in the Dow Jones?

No, Universe Pharmaceuticals is not included in the Dow Jones index

When was Universe Pharmaceuticals's last earnings report?

Universe Pharmaceuticals's most recent earnings report was on Feb 6, 2025

When does Universe Pharmaceuticals report earnings?

The date for Universe Pharmaceuticals's next earnings report has not been announced yet